Inhibition by retinol and butylated hydroxyanisole of carcinogen-mediated increases in guanylate cyclase activity and guanosine 3':5'-monophosphate accumulation.
D000818:Animals; D000840:Anisoles / Q000494:pharmacology*; D002083:Butylated Hydroxyanisole / Q000494:pharmacology*; D002273:Carcinogens / Q000037:antagonists & inhibitors; D003106:Colon / Q000187:drug effects / Q000378:metabolism; D006152:Cyclic GMP / Q000096:biosynthesis*; D004789:Enzyme Activation / Q000187:drug effects; D006162:Guanylate Cyclase / Q000378:metabolism*; D066298:In Vitro Techniques; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D008297:Male; D008769:Methylnitronitrosoguanidine / Q000037:antagonists & inhibitors*; D051381:Rats; D014801:Vitamin A / Q000494:pharmacology*
D000840:Anisoles; D002273:Carcinogens; D014801:Vitamin A; D008769:Methylnitronitrosoguanidine; D002083:Butylated Hydroxyanisole; D006162:Guanylate Cyclase; D006152:Cyclic GMP